Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Ravi

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
Clinical Sarcoma Research|May 17, 2012
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcomaDaniela Katz, Piyaporn Boonsirikamchai, Haeson Choi, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 5, 2020
Management of primary cardiac paragangliomaEdward Y Chan, Areeba Ali, Juan P Umana, et al.
Head & Neck|June 5, 2023
Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapyAlison K Yoder, Ahsan S Farooqi, Cort Wernz, et al.
Journal of Cutaneous Pathology|May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma seriesAlicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
Clinical Sarcoma Research|April 2, 2020
The immune microenvironment of uterine adenosarcomasAli Mohammed Refaat Ali, Jen-Wei Tsai, Cheuk Hong Leung, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
Clinical Sarcoma Research|May 14, 2013
The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysisMin S Park, Vinod Ravi, Anthony Conley, et al.
Clinical Sarcoma Research|June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypesJason Roszik, Wei-Lien Wang, John A Livingston, et al.
Cancers|March 13, 2025
Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare DiseaseRiddhi R Patel, Andrew J Bishop, Alexander J Lazar, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
Clinical Sarcoma Research|May 17, 2012
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcomaDaniela Katz, Piyaporn Boonsirikamchai, Haeson Choi, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 5, 2020
Management of primary cardiac paragangliomaEdward Y Chan, Areeba Ali, Juan P Umana, et al.
Head & Neck|June 5, 2023
Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapyAlison K Yoder, Ahsan S Farooqi, Cort Wernz, et al.
Journal of Cutaneous Pathology|May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma seriesAlicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
Clinical Sarcoma Research|April 2, 2020
The immune microenvironment of uterine adenosarcomasAli Mohammed Refaat Ali, Jen-Wei Tsai, Cheuk Hong Leung, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
Clinical Sarcoma Research|May 14, 2013
The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysisMin S Park, Vinod Ravi, Anthony Conley, et al.
Clinical Sarcoma Research|June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypesJason Roszik, Wei-Lien Wang, John A Livingston, et al.
Cancers|March 13, 2025
Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare DiseaseRiddhi R Patel, Andrew J Bishop, Alexander J Lazar, et al.
Pageof 11